In 2015 the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) informed DFSNZ about the results of Medsafe’s investigation into an internet drug supplier NZ Clenbuterol and provided DFSNZ details about the internet purchase in 2014 of a prohibited substance made by the rugby player Mathew Jeffreys.
Hereafter in February 2019 Drug Free Sport New Zealand (DFSNZ) has reported two anti-doping rule violations against Mathew Jeffreys for the use and possession of the prohibited substance Clenbuterol.
After notification the Athlete gave a prompt admission, denied the intentional use, waived his right to be heard, accepted a provisional suspension and the sanction proposed by DFSNZ.
The parties in this case reached an agreement and filed a joint memorandum in relation to the sanction for approval into a decision of the New Zealand Rugby Union Judicial Committee.
The New Zealand Rugby Union Judicial Committee considers that the Athlete gave a prompt admission and that there were substantial delays in the proceedings not attributed to the Athlete. Therefore the Committee decides on 30 March 2019 to impose a 2 year period of ineligibility on the Athlete starting backdated on 21 February 2018.
